3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
4
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Stomach Neoplasms
1
Skin Diseases
1
Neoplasms, Unknown Primary
1
Neoplasms by Site
1
Multiple Myeloma
1
Lymphoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Diseases
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
ipatasertib
×
Clear all
No trials found.